Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) FCF Margin (2020 - 2022)

Immuneering (IMRX) has 3 years of FCF Margin data on record, last reported at 2597344.18% in Q4 2022.

  • For Q4 2022, FCF Margin fell 259246418.0% year-over-year to 2597344.18%; the TTM value through Sep 2023 reached 10809489.45%, down 1080113559.0%, while the annual FY2022 figure was 14148.44%, 1266227.0% down from the prior year.
  • FCF Margin reached 2597344.18% in Q4 2022 per IMRX's latest filing, down from 28701.08% in the prior quarter.
  • Across five years, FCF Margin topped out at 511.54% in Q3 2020 and bottomed at 2597344.18% in Q4 2022.
  • Average FCF Margin over 3 years is 265287.05%, with a median of 3378.13% recorded in 2021.
  • Peak YoY movement for FCF Margin: plummeted -136471bps in 2021, then tumbled -259246418bps in 2022.
  • A 3-year view of FCF Margin shows it stood at 825.64% in 2020, then plummeted by -491bps to 4880.0% in 2021, then plummeted by -53124bps to 2597344.18% in 2022.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 2597344.18% in Q4 2022, 28701.08% in Q3 2022, and 10182.56% in Q2 2022.